Weixinkang made a wonderful appearance at CPHI China 2024

On June 19-21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China), sponsored by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., Ltd. was held at Shanghai New International Expo Center. The exhibition covers pharmaceutical raw materials, natural extracts, biopharmaceuticals, preparations and other fields, attracting nearly 3,500 exhibitors and more than 90,000 professionals at home and abroad.

Weixinkang Pharmaceutical with an open vision, actively into the process of globalization.The international business team brought Pediatric Multivitamins Injection（13）, Multivitamins For Injection (13)(10/3), Dopamine Hydrochloride Injection, Compound Amino Acid Injection (20AA) and other products to the exhibition, and explored industry development opportunities and expanded cooperation opportunities with pharmaceutical industry pioneers from all over the world.

Integrate into the international market at multiple levels and deepen business exchanges and cooperation industry pioneers from all over the world.

During the exhibition, Weixinkang booth visitors in an endless stream, many industry insiders to visit the booth to negotiate. The company's international business team has negotiated and exchanged business cooperation with customers from Russia, Uzbekistan, India, Vietnam, Philippines, Brazil, Sri Lanka, UAE, Saudi Arabia, Congo and other countries/regions, as well as relevant departments of Fresenius Kabi, Sanofi and other internationally renowned pharmaceutical groups. The latest progress and achievements of the company in R&D platform building, diversified product pipeline, capacity construction, production and quality control were comprehensively introduced, and the advantages and layout of the company in the fields of intravenous vitamins, intravenous trace elements and intravenous electrolytes were emphatically displayed. It demonstrates the brand strength of Weixinkang Medicine from multiple perspectives and lays a good foundation for further expanding international business.

Two-way search for cooperation opportunities, talk about the development trend of the industry 

In the three-day exhibition, the international business team actively interviewed new and old customers, and had in-depth face-to-face exchanges with exhibitors from more than 30 countries/regions around the world, showing the strength of Weixinkang in the field of parenteral nutrition, the latest research and development achievements and international layout from multiple dimensions, fully demonstrating the professional and international corporate image. The team also took this opportunity to talk with many customers, actively listen to customer feedback and suggestions, not only strengthened the continuous in-depth cooperation with existing customers, but also established contact with new customers, and collected a lot of market feedback and customer demand information. By analyzing the development trend of the industry where opportunities and challenges coexist, it plays a positive role in promoting cooperation and development, seeking mutually beneficial business opportunities for cooperation and win-win cooperation, and promoting the company's overseas business layout.

At this Shanghai CPHI exhibition, Weixinkang Pharmaceutical has gained a full harvest, showing its confidence, determination and strength in exchanges and cooperation with global apis and pharmaceutical companies.

Looking forward to the future, Weixinkang Pharmaceutical's international business development road is bumpy, we will seek up and down, forge ahead, create new growth for the company, and actively pursue higher goals.